NCT02138097 Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Status COMPLETED Phase N/A
NCT02137226 BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02133482 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667 Status WITHDRAWN Phase PHASE1
NCT02131155 LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy Status TERMINATED Phase PHASE3
NCT02129192 Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use Status COMPLETED Phase PHASE1
NCT02126865 Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients Status COMPLETED Phase PHASE1
NCT02126826 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee Status COMPLETED Phase PHASE1
NCT02123823 BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02121535 Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use Status COMPLETED Phase PHASE1
NCT02121522 A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration Status COMPLETED Phase PHASE2
NCT02121509 Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02121483 Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02115048 Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone Status TERMINATED Phase PHASE2
NCT02114671 A Study to Investigate the Phototoxic Potential of Faldaprevir Status WITHDRAWN Phase PHASE1
NCT02109679 Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02106923 Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets Status COMPLETED Phase PHASE1
NCT02106247 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers Status COMPLETED Phase PHASE1